Mergers & Acquisitions
Jun. 23, 2015
Dealmakers
A roundup of recent transactions across the state and the lawyers involved.
Kythera Biopharmaceuticals taps Latham for $2.1B sale to Allergan
Kythera Biopharmaceuticals Inc., makers of an FDA-approved drug designed to reduce
neck fat, relied on longtime adviser Latham & Watkins LLP in its cash and equity sale
to Botox maker Allerga...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In